NCT04161768View on ClinicalTrials.gov

Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

PHASE3RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

December 1, 2028

Study Completion Date

December 1, 2028

Conditions
Spontaneous Bacterial Peritonitis
Interventions
DRUG

Norfloxacin

Norfloxacin 400 mg daily

DRUG

Itopride

Itopride 50 mg three times daily

Trial Locations (1)

Unknown

RECRUITING

Sherief Abd-Elsalam, Tanta

All Listed Sponsors
lead

Tanta University

OTHER